<?xml version="1.0" encoding="UTF-8"?>
<p>The data currently available do not allow definitive conclusions, whether favorable or not, about the efficacy of specific therapies or between different drug therapies. Currently, recommendations are mainly based on previous experience acquired with epidemics or by extrapolating specialistsâ€™ experiences with these drugs in chronic rheumatological diseases. However, with the emergence of new, high-quality scientific evidence, these recommendations can be adjusted. </p>
